Generics in China
Generics in China
SUMMARY
Generics in China industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Generics in China industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Chinese generics market had total revenues of $69.8bn in 2019, representing a compound annual growth rate (CAGR) of 8.5% between 2015 and 2019.
- Market consumption volume increased with a CAGR of 3.2% between 2015 and 2019, to reach a total of 96.5% in 2019.
- China is the second largest market in the world after the US and one of the fastest growing.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in China
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in China
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the China generics market with five year forecasts by both value and volume
- What was the size of the China generics market by value in 2019?
- What will be the size of the China generics market in 2024?
- What factors are affecting the strength of competition in the China generics market?
- How has the market performed over the last five years?
- How large is China’s generics market in relation to its regional counterparts?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Teva Pharmaceutical Industries Limited
8.2. Mylan N.V.
8.3. China Grand Pharmaceutical and Healthcare Holdings Limited
8.4. Pfizer Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Teva Pharmaceutical Industries Limited
8.2. Mylan N.V.
8.3. China Grand Pharmaceutical and Healthcare Holdings Limited
8.4. Pfizer Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: China generics market value: $ billion, 2015-19
Table 2: China generics market volume: % of total pharma, 2015-19
Table 3: China generics market geography segmentation: $ billion, 2019
Table 4: China generics market value forecast: $ billion, 2019-24
Table 5: China generics market volume forecast: % of total pharma, 2019-24
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Mylan N.V.: key facts
Table 10: Mylan N.V.: Annual Financial Ratios
Table 11: Mylan N.V.: Key Employees
Table 12: China Grand Pharmaceutical and Healthcare Holdings Limited: key facts
Table 13: China Grand Pharmaceutical and Healthcare Holdings Limited: Annual Financial Ratios
Table 14: China Grand Pharmaceutical and Healthcare Holdings Limited: Key Employees
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: Annual Financial Ratios
Table 17: Pfizer Inc.: Key Employees
Table 18: Pfizer Inc.: Key Employees Continued
Table 19: China size of population (million), 2015-19
Table 20: China gdp (constant 2005 prices, $ billion), 2015-19
Table 21: China gdp (current prices, $ billion), 2015-19
Table 22: China inflation, 2015-19
Table 23: China consumer price index (absolute), 2015-19
Table 24: China exchange rate, 2015-19
Table 1: China generics market value: $ billion, 2015-19
Table 2: China generics market volume: % of total pharma, 2015-19
Table 3: China generics market geography segmentation: $ billion, 2019
Table 4: China generics market value forecast: $ billion, 2019-24
Table 5: China generics market volume forecast: % of total pharma, 2019-24
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Mylan N.V.: key facts
Table 10: Mylan N.V.: Annual Financial Ratios
Table 11: Mylan N.V.: Key Employees
Table 12: China Grand Pharmaceutical and Healthcare Holdings Limited: key facts
Table 13: China Grand Pharmaceutical and Healthcare Holdings Limited: Annual Financial Ratios
Table 14: China Grand Pharmaceutical and Healthcare Holdings Limited: Key Employees
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: Annual Financial Ratios
Table 17: Pfizer Inc.: Key Employees
Table 18: Pfizer Inc.: Key Employees Continued
Table 19: China size of population (million), 2015-19
Table 20: China gdp (constant 2005 prices, $ billion), 2015-19
Table 21: China gdp (current prices, $ billion), 2015-19
Table 22: China inflation, 2015-19
Table 23: China consumer price index (absolute), 2015-19
Table 24: China exchange rate, 2015-19
LIST OF FIGURES
Figure 1: China generics market value: $ billion, 2015-19
Figure 2: China generics market volume: % of total pharma, 2015-19
Figure 3: China generics market geography segmentation: % share, by value, 2019
Figure 4: China generics market value forecast: $ billion, 2019-24
Figure 5: China generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the generics market in China, 2019
Figure 7: Drivers of buyer power in the generics market in China, 2019
Figure 8: Drivers of supplier power in the generics market in China, 2019
Figure 9: Factors influencing the likelihood of new entrants in the generics market in China, 2019
Figure 10: Factors influencing the threat of substitutes in the generics market in China, 2019
Figure 11: Drivers of degree of rivalry in the generics market in China, 2019
Figure 1: China generics market value: $ billion, 2015-19
Figure 2: China generics market volume: % of total pharma, 2015-19
Figure 3: China generics market geography segmentation: % share, by value, 2019
Figure 4: China generics market value forecast: $ billion, 2019-24
Figure 5: China generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the generics market in China, 2019
Figure 7: Drivers of buyer power in the generics market in China, 2019
Figure 8: Drivers of supplier power in the generics market in China, 2019
Figure 9: Factors influencing the likelihood of new entrants in the generics market in China, 2019
Figure 10: Factors influencing the threat of substitutes in the generics market in China, 2019
Figure 11: Drivers of degree of rivalry in the generics market in China, 2019